erlotinib has been researched along with salmeterol xinafoate in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (salmeterol xinafoate) | Trials (salmeterol xinafoate) | Recent Studies (post-2010) (salmeterol xinafoate) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 46 | 0 | 25 |
| Protein | Taxonomy | erlotinib (IC50) | salmeterol xinafoate (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.005 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.5012 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chellappan, DK; Collet, TA; Dighe, SN; Dua, K; Ekwudu, O; Katavic, PL | 1 |
1 review(s) available for erlotinib and salmeterol xinafoate
| Article | Year |
|---|---|
Recent update on anti-dengue drug discovery.
Topics: Animals; Antiviral Agents; Biological Products; Cell Line, Tumor; Dengue Virus; Drug Discovery; Humans; Serine Proteinase Inhibitors; Viral Nonstructural Proteins; Virus Replication | 2019 |